Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $7.68 Million - $8.37 Million
-124,125 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $5.76 Million - $8.37 Million
-124,125 Reduced 50.0%
124,125 $6.92 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $12.2 Million - $15.9 Million
248,250 New
248,250 $15.9 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Selkirk Management LLC Portfolio

Follow Selkirk Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Selkirk Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Selkirk Management LLC with notifications on news.